Your browser doesn't support javascript.
loading
7-(2-Thienyl)-7-Deazaadenosine (AB61), a New Potent Nucleoside Cytostatic with a Complex Mode of Action.
Perlíková, Pavla; Rylová, Gabriela; Naus, Petr; Elbert, Tomás; Tloustová, Eva; Bourderioux, Aurelie; Slavetínská, Lenka Postová; Motyka, Kamil; Dolezal, Dalibor; Znojek, Pawel; Nová, Alice; Harvanová, Monika; Dzubák, Petr; Siller, Michal; Hlavác, Jan; Hajdúch, Marián; Hocek, Michal.
Afiliação
  • Perlíková P; Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Gilead Sciences & IOCB Research Center, Prague, Czech Republic.
  • Rylová G; Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University and University Hospital in Olomouc, Olomouc, Czech Republic.
  • Naus P; Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Gilead Sciences & IOCB Research Center, Prague, Czech Republic.
  • Elbert T; Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Gilead Sciences & IOCB Research Center, Prague, Czech Republic.
  • Tloustová E; Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Gilead Sciences & IOCB Research Center, Prague, Czech Republic.
  • Bourderioux A; Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Gilead Sciences & IOCB Research Center, Prague, Czech Republic.
  • Slavetínská LP; Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Gilead Sciences & IOCB Research Center, Prague, Czech Republic.
  • Motyka K; Department of Organic Chemistry, Faculty of Natural Sciences, Palacky University, Olomouc, Czech Republic.
  • Dolezal D; Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University and University Hospital in Olomouc, Olomouc, Czech Republic.
  • Znojek P; Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University and University Hospital in Olomouc, Olomouc, Czech Republic.
  • Nová A; Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University and University Hospital in Olomouc, Olomouc, Czech Republic.
  • Harvanová M; Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University and University Hospital in Olomouc, Olomouc, Czech Republic.
  • Dzubák P; Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University and University Hospital in Olomouc, Olomouc, Czech Republic.
  • Siller M; Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University and University Hospital in Olomouc, Olomouc, Czech Republic.
  • Hlavác J; Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University and University Hospital in Olomouc, Olomouc, Czech Republic. Department of Organic Chemistry, Faculty of Natural Sciences, Palacky University, Olomouc, Czech Republic.
  • Hajdúch M; Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacky University and University Hospital in Olomouc, Olomouc, Czech Republic. hocek@uochb.cas.cz marian.hajduch@upol.cz.
  • Hocek M; Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Gilead Sciences & IOCB Research Center, Prague, Czech Republic. Department of Organic Chemistry, Faculty of Science, Charles University in Prague, Prague, Czech Republic. hocek@uochb.cas.cz marian.hajduch
Mol Cancer Ther ; 15(5): 922-37, 2016 05.
Article em En | MEDLINE | ID: mdl-26819331

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tubercidina / Antineoplásicos Limite: Animals / Humans Idioma: En Revista: Mol Cancer Ther Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tubercidina / Antineoplásicos Limite: Animals / Humans Idioma: En Revista: Mol Cancer Ther Ano de publicação: 2016 Tipo de documento: Article